Management of Childhood Pancytopenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pancytopenia is an important hematologic Problem.it is a decrease in all three cellular elements of peripheral blood leading to aneamia, leucopenia and thrombocytopenia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection of Blood From Patients With Pancytopenia

NCT00001214

Pancytopenia

COMPLETED

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT06531018

Primary Immune Thrombocytopenia

RECRUITING PHASE1/PHASE2

Value of Platelet Indices as Predictive Factor in Thrombocytopenia

NCT05116033

Main Focus of the Study

UNKNOWN

IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP

NCT04482777

ITP

UNKNOWN

Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia

NCT03243656

Eltrombopag

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pancytopenia usually presents with symptoms of bone marrow failure such as pallor, dysnea, brusing and increased tendency to infections.

The incidence of various disorders causing pancytopenia varies according to Geographical distribution and genetic mutations. It can result from :

* Failure of production of hematopoietic progenitors in bone marrow as in aplastic aneamia.
* Bone marrow infiltration by malignant cells as in acute leukemia.
* Antibodies mediated bone marrow suppression as in systemic lupus.
* Ineffective hematopoiesis and dysplasia as in nutrition deficiency.
* Peripheral sequestration of blood cells in over active reticuloendothelial system as in hypersplenism.

Pancytopenia is not a disease entity but a triad of findings that may result from primary or secondary bone marrow involvement.

Bone marrow aspiration and biopsy evaluation along with clinical correlation are important to evaluate the causes of pancytopenia and plan further investigations and treatment.

Pancytopenia can result from damage to bone marrow evidanced by low reticulocyte count, or increased destruction of the peripheral blood with increased reticulocyte count.

Bone marrow examination is a simple and safe invasive procedure for evaluating the causes of pancytopenia.

The hypoplastic marrow which occurs in 2% of pediatrics acute lymphoblastic leukemia may be misdiagnosed as aplastic aneamia.

Studies done have shown leukemia to be the second most common cause of pancytopenia in pediatrics, marginally behind aplastic aneamia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancytopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

One group of children below 18 years old

Complete blood picture

Intervention Type DIAGNOSTIC_TEST

Iaboratory investigation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Complete blood picture

Iaboratory investigation

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All childrens and adolescents suffering from pancytopenia attending heamatology unit of pediatric department Assiut University Hospital will be included.